HK1069986A1 - Topical application of thiazolyl amides - Google Patents
Topical application of thiazolyl amidesInfo
- Publication number
- HK1069986A1 HK1069986A1 HK05102703.9A HK05102703A HK1069986A1 HK 1069986 A1 HK1069986 A1 HK 1069986A1 HK 05102703 A HK05102703 A HK 05102703A HK 1069986 A1 HK1069986 A1 HK 1069986A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- alkyl
- halo
- het
- mono
- alkoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10129714A DE10129714A1 (de) | 2001-06-22 | 2001-06-22 | Topische Anwendung von Thiazolylamiden |
PCT/EP2002/006327 WO2003000259A1 (de) | 2001-06-22 | 2002-06-10 | Topische anwendung von thiazolylamiden |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1069986A1 true HK1069986A1 (en) | 2005-06-10 |
Family
ID=7688817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05102703.9A HK1069986A1 (en) | 2001-06-22 | 2005-03-31 | Topical application of thiazolyl amides |
Country Status (18)
Country | Link |
---|---|
US (1) | US7883713B2 (pt) |
EP (2) | EP1401435B1 (pt) |
JP (1) | JP4342304B2 (pt) |
KR (1) | KR100899491B1 (pt) |
CN (1) | CN1535149B (pt) |
AT (2) | ATE464047T1 (pt) |
AU (1) | AU2002345023B2 (pt) |
BR (1) | BRPI0210601B8 (pt) |
CA (1) | CA2451552C (pt) |
DE (3) | DE10129714A1 (pt) |
DK (2) | DK1629842T3 (pt) |
ES (2) | ES2260449T3 (pt) |
HK (1) | HK1069986A1 (pt) |
IL (1) | IL159258A0 (pt) |
MX (1) | MXPA03011518A (pt) |
PL (1) | PL208927B1 (pt) |
PT (2) | PT1401435E (pt) |
WO (1) | WO2003000259A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10129715A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Thiazolylamide |
DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
JP5837936B2 (ja) * | 2010-11-01 | 2015-12-24 | ロマーク ラボラトリース,エル.シー. | アルキルスルフィニル置換チアゾリド化合物 |
EP2573086A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
EP2573085A1 (en) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
CA3018026A1 (en) | 2016-04-06 | 2017-10-12 | Innovative Molecules Gmbh | Aminothiazole derivatives useful as antiviral agents |
TWI753972B (zh) | 2016-11-28 | 2022-02-01 | 德商艾庫瑞斯公司 | N-[5-(胺基磺醯基)-4-甲基-1,3-噻唑-2-基]-n-甲基-2-[4-(2-吡啶基)-苯基]-乙醯胺之游離鹼的順丁烯二酸鹽,醫藥調配物、製造方法及其用途 |
UY37497A (es) * | 2016-11-28 | 2018-06-29 | Aicuris Anti Infective Cures Gmbh | Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida |
KR102622289B1 (ko) | 2016-11-28 | 2024-01-05 | 아이쿠리스 게엠베하 운트 코. 카게 | N-[5-(아미노술포닐)-4-메틸-1,3-티아졸-2-일]-n-메틸-2-[4-(2-피리디닐)-페닐]-아세트아미드 유리 염기 반수화물, 그의 제조 방법 및 용도 |
AU2018344471B2 (en) | 2017-10-05 | 2022-09-29 | Innovative Molecules Gmbh | Enantiomers of substituted thiazoles as antiviral compounds |
CA3168721A1 (en) * | 2020-03-26 | 2021-09-30 | Jessica Redmer | Ophthalmic formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3- thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide hemihydrate |
EP3925595A1 (en) * | 2020-06-17 | 2021-12-22 | AiCuris GmbH & Co. KG | Ophthalmic formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl] acetamide hemihydrate |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3658830A (en) * | 1970-01-16 | 1972-04-25 | Shell Oil Co | 5-(substituted mercapto sulfiny sulfonyl or sulfamoyl) |
CH564301A5 (pt) | 1970-01-16 | 1975-07-31 | Shell Int Research | |
US3717651A (en) * | 1970-04-20 | 1973-02-20 | Shell Oil Co | Thiazoles |
US3847588A (en) * | 1970-04-20 | 1974-11-12 | Shell Oil Co | Thiazoles herbicidal |
GB2080682B (en) * | 1980-07-30 | 1984-03-28 | Ciba Geigy Ag | Antiherpetically active lipstick |
US4556560A (en) * | 1983-01-24 | 1985-12-03 | The Procter & Gamble Company | Methods for the treatment and prophylaxis of diaper rash and diaper dermatitis |
DE3319282A1 (de) * | 1983-05-27 | 1984-11-29 | Gödecke AG, 1000 Berlin | Verwendung von adenosin bei der behandlung von herpes |
PL327582A1 (en) | 1995-12-29 | 1998-12-21 | Boehringer Ingelheim Pharma | Derivatives of phenylthiazole exhibiting antiviral properties against herpes virues |
US5705344A (en) | 1996-03-14 | 1998-01-06 | Tularik, Inc. | High-throughput screening assay for inhibitors of nucleic acid helicases |
GB2311068A (en) | 1996-03-14 | 1997-09-17 | Merck & Co Inc | Helicase isolated from human cytomegalovirus (HCMV) |
GB2311069A (en) | 1996-03-14 | 1997-09-17 | Merck & Co Inc | Primase isolated from human cytomegalovirus (HCMV) |
CA2223032A1 (en) | 1997-02-21 | 1998-08-21 | Smithkline Beecham Corporation | Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents |
DE19802437A1 (de) | 1998-01-23 | 1999-07-29 | Bayer Ag | Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe |
AU3289299A (en) | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
AU743489B2 (en) | 1998-03-19 | 2002-01-24 | Pharmacia & Upjohn Company | 1,3,4-thiadiazoles useful for the treatment of CMV infections |
CA2366607A1 (en) * | 1999-03-08 | 2000-09-14 | Bayer Aktiengesellschaft | Thiazolyl urea derivatives and their utilization as antiviral agents |
DOP2000000109A (es) * | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
EP1319185A1 (en) * | 2000-06-15 | 2003-06-18 | Bayer Aktiengesellschaft | Method for identifying compounds with anti-herpes activity |
DE10129716A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Kombinationspräparate zur Herpes-Behandlung |
DE10131128A1 (de) | 2001-06-28 | 2003-01-16 | Bayer Ag | Sekundäre Sulfonamide |
WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
-
2001
- 2001-06-22 DE DE10129714A patent/DE10129714A1/de not_active Withdrawn
-
2002
- 2002-06-10 DE DE50214378T patent/DE50214378D1/de not_active Expired - Lifetime
- 2002-06-10 JP JP2003506904A patent/JP4342304B2/ja not_active Expired - Lifetime
- 2002-06-10 PL PL364378A patent/PL208927B1/pl unknown
- 2002-06-10 CN CN028125304A patent/CN1535149B/zh not_active Expired - Lifetime
- 2002-06-10 AT AT05024999T patent/ATE464047T1/de active
- 2002-06-10 ES ES02743172T patent/ES2260449T3/es not_active Expired - Lifetime
- 2002-06-10 DK DK05024999.4T patent/DK1629842T3/da active
- 2002-06-10 AU AU2002345023A patent/AU2002345023B2/en not_active Expired
- 2002-06-10 MX MXPA03011518A patent/MXPA03011518A/es active IP Right Grant
- 2002-06-10 WO PCT/EP2002/006327 patent/WO2003000259A1/de active IP Right Grant
- 2002-06-10 IL IL15925802A patent/IL159258A0/xx active IP Right Grant
- 2002-06-10 AT AT02743172T patent/ATE320253T1/de active
- 2002-06-10 CA CA2451552A patent/CA2451552C/en not_active Expired - Lifetime
- 2002-06-10 KR KR1020037016645A patent/KR100899491B1/ko active IP Right Grant
- 2002-06-10 DE DE50206084T patent/DE50206084D1/de not_active Expired - Lifetime
- 2002-06-10 DK DK02743172T patent/DK1401435T3/da active
- 2002-06-10 PT PT02743172T patent/PT1401435E/pt unknown
- 2002-06-10 ES ES05024999T patent/ES2341778T3/es not_active Expired - Lifetime
- 2002-06-10 US US10/481,680 patent/US7883713B2/en active Active
- 2002-06-10 BR BRPI0210601A patent/BRPI0210601B8/pt not_active IP Right Cessation
- 2002-06-10 EP EP02743172A patent/EP1401435B1/de not_active Expired - Lifetime
- 2002-06-10 PT PT05024999T patent/PT1629842E/pt unknown
- 2002-06-10 EP EP05024999A patent/EP1629842B1/de not_active Expired - Lifetime
-
2005
- 2005-03-31 HK HK05102703.9A patent/HK1069986A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1069986A1 (en) | Topical application of thiazolyl amides | |
RU2454415C9 (ru) | Производное индола | |
EA199800912A1 (ru) | Дигидратная соль мезилата 5-(2-(4-(1,2-бензизотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2(1н)-индол-2-она, фармацевтическая композиция и способ лечения психотического расстройства | |
RU2002124873A (ru) | Глюкопиранозилоксибензилбензольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для получения указанных производных | |
DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
HRP20100714T1 (hr) | Derivati 5-(benz-(z)-iliden)-tiazolidin-4-ona kao imunosupresivna sredstva | |
SI20975B (sl) | N-/5-///5-alkil-2-oksazolil/metil/tio/-2-tiazolil/-karboksamidni inhibitorji ciklodekstrin odvisne kinaze | |
MY128051A (en) | Mesylate trihydrate salt of 5-(2-(4-(1, 2-benzisothiazol-3 -yl)-1-piperazinyl)ethyl)-6-chloro-1, 3-dihydro-2-(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist | |
KR970704690A (ko) | 통증 완화제인 방향족 아미노 에테르(aromatic amino ethers as pain relieving agents) | |
RU2008127254A (ru) | Производные тиадиазола как противодиабетические средства | |
BR0112856A (pt) | Método para o tratamento dos distúrbios, composto ou um sal ou solvato deste, processo para a preparação dos mesmos, composição farmacêutico, método de tratamento e/ou profilaxia de um ou mais dos distúrbios, uso de um composto, e, método para o tratamento de diabetes, grande depressão, depressão manìaca, ansiedade, esquizofrenia e distúrbios do sono, em mamìferos humanos e não humanos | |
ATE250573T1 (de) | Azetidin- und pyrrolidinderivate | |
KR890005069A (ko) | 치환된 1-[아르알킬- 피페라지노알킬]사이클로알칸올 | |
ES8602694A1 (es) | Un procedimiento para la obtencion de derivados de amino-pirimidina | |
AR032598A1 (es) | Oxazinquinolonas, una composicion farmaceutica y el uso de las mismas para preparar un medicamento utiles en el tratamiento de infecciones virales | |
FR2780649B1 (fr) | Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine | |
NO964773L (no) | Tiadiazoler og deres anvendelse som antipicornavirale midler | |
JP2008528697A (ja) | 癌の病因に関連するウィルス感染症を治療するためのアミン誘導体含有組成物および方法 | |
KR970059173A (ko) | (1h-인돌-4-일)-피페리딘 또는 테트라하이드로피리딘 에틸아민 및 에틸카복스아미드 | |
HUT56549A (en) | Process for producing new imidazole derivatives and pharmaceutical compositions comprising such imidazole derivatives as active ingredient | |
RU2003105827A (ru) | Средства против слабоумия, содержащие производные 2-арил-8-оксодигидропурина, в качестве активного ингредиента | |
PE20030038A1 (es) | N-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]carboxamidas inhibidoras de cinasas dependientes de la ciclina | |
BR9815690A (pt) | Composto, processo para a preparação de qualquer um dos compostos, composição farmacêutica, e, uso do composto de 3-(nafter-1-il-óxi) - pirrolidina, 3-(5,6,7,8 - tetraidro-nafterc-1-il-óxi) - pirrolindina | |
FR2869034A1 (fr) | Derive du 14,15-dihydro 20,21-dinoreburnamenin 14-ol et leur utilisation pour le traitement des depressions | |
ES8506735A1 (es) | Procedimiento para la produccion de acidos carboxilicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20220609 |